You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fallopian Tube Neoplasms

Showing 1 - 25 of 5,624
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)

Not yet recruiting
  • Primary Ovarian Cancer
  • +2 more
  • Huaier granule
  • (no location specified)
Mar 29, 2023

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)

Not yet recruiting
  • Cancer
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center - University of Minnesota
Jan 24, 2023

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
May 12, 2023

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Odense, Denmark
  • +3 more
Oct 16, 2023

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Homologous Recombination Inquiry Through Ovarian Malignancy

Completed
  • Ovarian Cancer
  • +2 more
    • Niigata city, Niigata Prefecture, Japan
      Niigata University Graduate School of Medical and Dental Science
    Jan 19, 2023

    Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

    Not yet recruiting
    • Stage III Ovarian Cancer
    • +5 more
    • (no location specified)
    Dec 12, 2022

    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)

    Completed
    Has Results
    • Fallopian Tube Cancer
    • +2 more
    • NY-ESO-1 peptide vaccine
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Microdevice)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Microdevice
    • Boston, Massachusetts
    • +1 more
    Jul 12, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Tampa (Aspirin 325mg, Placebo)

    Suspended
    • Ovarian Cancer
    • +2 more
    • Aspirin 325mg
    • Placebo
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 12, 2022

    Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)

    Recruiting
    • Cervical Cancer
    • +4 more
    • Patient registry
    • Seoul, Korea, Republic of
      Department of Obstetrics and Gynecology, University of Ulsan Col
    Jun 12, 2023

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Effectiveness in Ovarian Cancer

    Completed
    • Ovarian Cancer
    • +5 more
    • Baseline Biopsy
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • New Orleans, Louisiana
    • +3 more
    Dec 16, 2022

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • New Haven, Connecticut
    • +1 more
    Jan 11, 2023

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Houston (Telephone Counseling, Usual Care)

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • Telephone Counseling
    • Usual Care
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 22, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 13, 2023

    Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors, Peritoneal Tumors Trial in Montpellier (Biological collection)

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • +2 more
    • Biological collection
    • Montpellier, France
      ICM - Institut régional du Cancer Montpellier
    Mar 11, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • carboplatin and paclitaxel followed by surgery
    • Bologna, Italy
    • +4 more
    Dec 28, 2022